CN110585256A - 平卧菊三七制剂 - Google Patents
平卧菊三七制剂 Download PDFInfo
- Publication number
- CN110585256A CN110585256A CN201910921005.0A CN201910921005A CN110585256A CN 110585256 A CN110585256 A CN 110585256A CN 201910921005 A CN201910921005 A CN 201910921005A CN 110585256 A CN110585256 A CN 110585256A
- Authority
- CN
- China
- Prior art keywords
- preparation
- gynura procumbens
- procumbens
- powder
- fresh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
Abstract
平卧菊三七制剂,是采用低热恒温法制取制剂,先用平卧菊三七鲜品进行榨汁、过滤、然后使用控制在50度温度的恒温烤房、进行干燥、粉碎制成(堂专家平卧菊三七)制剂,制剂可清热解毒、凉血、活血、止血、增强人体免疫力,对风湿骨痛、颈椎病、腰椎病、心脑血管病、痛风、头痛、头昏、抽筋、脑梗塞、中风后遗症、脑萎缩、脑血管硬化、乙肝、血吸虫病、高血压、高血脂、高血糖、感冒、咳嗽、哮喘有很好的治疗作用,有效率在90%以上。
Description
技术领域:本发明为药食同源制剂领域,具体是平卧菊三七制剂。
背景技术:随着社会的快速发展,环境的不但变化,亚键康人越来越多,部分人对养生、健身的认识不够,随着年龄的增大,免疫力越来越低,对自已的身体调理没有引起重视,日积月垒、到最后久治不愈转发成为重大的疑难病;这些病症现已成上升趋势,如风湿骨痛、颈推病、腰椎病、心脑血管病,随处可见,目前治疗此类病的中西药虽然品种繁多,但大都效果不佳、须常年用药,而且副作用大、造成多种并发症,为此人们急需有一种能有效治疗以上多种病、而且无毒副作用、能长期使用的药食制品问世,本人在行医过程中将单味平卧菊三七、使用低热恒温制剂法、制成制剂,用于临床对很多疑难病取得了重大突破,平卧菊三七:经化学成份研究、富含有机钙,是中老年人最佳的补钙绿色食品;含有丰富的有机酸成分及黄酮类化合物,有机酸成分中新氯原酸具有很好的抗病毒和增强人体免疫力功效,对抑制乙型肝炎病毒有显著的作用,还具有抗艾滋病病毒以及流感病毒,可清热解毒、止血止咳、减少血管紫癜、泻火、凉血、消炎、生津等功效,对于肿病有一定的疗效,它全身都是宝,经安全性评价研究,平卧菊三七可作为一种无毒级的优质特种保健蔬菜,根茎是中成药上佳的原材料,外用对带状疱疹、各种皮炎、烫伤、烧伤及无名肿痛均有良好的疗效,还可以止血、止痛、止痒及护肤保湿抗衰老,它是一种药食兼可的独特植物,食味柔滑,清香可口,其叶也可生吃,取鲜叶用开水冲泡当茶饮,可补钙、抗病毒、抗感冒、提高免疫力、通经活络,消炎止咳,散瘀消肿,活血生肌,可有效治疗乙肝、跌打损伤、风湿关节痛、痛风、颈椎病、腰椎病、心脑血管、感冒、咳嗽,这些作用是人们长期食用整结出来的、已得人们的公认,然而本人采用多种方法将其制成制剂后服用发现,使用鲜品的疗效明显优于任何一种制剂,为解决这一问题,本公司成立研化团队,组建新运堂专家组、进行技术攻关,对平卧菊三七所含的化学成份进行进一步研究,发现它含有很多易挥发的化学成份,最后认定是加工产品时,原料通过高温加热、造成原料中所含的一些易挥发的化学成份流失,从而导至疗效减弱,使用鲜品、一不方便保存、二又不方便食用、加大了产品的推广的难度,为解决此难题、本公司发明了一种平卧菊三七低热恒温制取法、解决了以上难题、并使产品的疗效远超于鲜品和采用其它方法制成的制剂,并保持了它本身的原生态,同时将此产品定名为<堂专家平卧菊三七>,通过上千名亚键康患者试用,发现对风湿骨痛、颈椎病、腰椎病、心脑血管病、痛风、头痛、头昏、抽筋、脑梗塞、中风后遗症、脑萎缩、脑血管硬化、乙肝、血吸虫病、高血压、高血脂、高血糖、补钙、感冒、咳嗽、哮喘的治疗效果显著,同时和采用其它方法(高温提取、浓缩、日晒干品原料进行制剂.......等)制取的制剂进行了对比试用,发现采用低热恒温制剂法制得的(堂专家平卧菊三七)制剂疗效远优于其它方法制得的制剂,而且制备方法简单、原材料的利用率高,保持了植物的原生态,提高了产品的疗效,增加了使用范围、减少了制剂的使用量、具有良好的开发前景。
发明内容:平卧菊三七制剂是:采用的低热恒温提取法提取其有效成份、从而保持了它的原生态和自身具有的特有功效,再通过提高它的浓缩比使其疗效倍增,经化学成份研究、平卧菊三七主要食用嫩茎叶,经检测,其主要成分如下:氨基酸0.87%,维生素C、11.2mg/100g,蛋白质、1.24%,维生素B1、0.020mg/100g,总糖1.5%,维生素B2、0.088mg/100g,膳食纤维2.40g/100g,绿原酸0.31mg/100g,钙122.1mg/100g,总黄酮0.010%,铁12.4mg/100g,脂肪0.79%,锌0.4mg/100g,水份93.94%;全草的化学成分(参考:期刊2018年11期),方法采用硅胶、Sephadex LH-20、反相ODS等技术进行分离纯化;通过理化性质、核磁、质谱等方法鉴定化合物结构,结果从平卧菊三七乙醇提取物中分离得到了26个化合物,分别鉴定为邻苯二甲酸二丁酯(1)、熊果酸(2)、山柰酚-3-O-β-D-葡萄糖苷(3)、5-hydroxymaltol(4)、对羟基苯甲酸(5)、4-氨基肉桂酸(6)、(E)-2-hexenylβ-D-glucoside(7)、1-(3-indolyl)-2,3-dihydroxy-propan-1-one(8)、山柰酚-7-O-β-D-葡萄糖苷(9)、槲皮素-3-O-β-D-吡喃葡萄糖苷(10)、3,4,5-三咖啡酰基奎宁酸甲酯(11)、芦丁(12)、橙皮苷(13)、3,4-dihydroxyphenylacetic acid methyl ester(14)、刺梨酸(15)、委陵菜酸(16)、2-methoxy-4-(2-propenyl)-phenyl-O-β-D-glucopyranoside(17)、negletein(18)、没食子酸-3-甲基醚(19)、caesalpiniaphenol D(20)、2,5-二羟基苯甲酸(21)、原儿茶醛(22)、isohematinic acid(23)、icariside B1(24)、dendranthemoside B(25)、4-甲氧基肉桂酸(26)、黄芩苷(27),结论化合物4、6~9、11、13~27为首次从菊三七属植物中分离得到,化合物1、2、10和12为首次从平卧菊三七中分离得到;所检验的这些化合物有很多在高温下易于挥发,因此通过长时间的爆晒和高温提取,很多易挥发成份也随水的蒸发而流失,从而使制剂的疗效达不到使用鲜品的效果,公司经长期研化、发明了低热恒温制剂法,解决了平卧菊三七制剂后存在的缺限(疗效相比鲜品减弱),使用平卧菊三七低热恒温制剂法制得的制剂、疗效明显优于其它方法制得的制剂的疗效。
平卧菊三七低热恒温制剂法的流程如下:1、取少量的平卧菊三七鲜茎叶经凉干、消毒、制成精细粉,然后贮藏备用;2、将大量鲜平卧菊三七用大型榨汁机,进行榨汁碎取;3、将榨汁后的平卧三七进行液、渣过滤,让液渣分离(为提高利用率、滤渣可加入适量食用酒精泡上2天左右进行重复过滤),4、将滤液加入第1步所制备的平卧菊三七粉适量、制成液粉混合物(通过加入的制备粉的多少来确定产品浓缩比的比例),然后平布于不锈钢平板上(或盆中)、然后在50度的恒温烤房中进行干燥;5、将干燥品进行粉碎后、用红外线进行杀菌,然后包装、贮存备用。
制备方法一、平卧菊三七低热恒温制剂的制备方法:取平卧菊三七鲜品100kg,严格按照平卧三七低温制剂法的规程,将其制成3kg的浓缩粉,然后用瓶装备用,并命名为堂专家平卧菊三七。
制备方法二、平卧菊三七常用水提<或醇提>法:取平卧菊三七鲜品100Kg,先在日光下晒干、然后打粉,进行多次提取液体、进行浓缩、消毒、制成3kg的浓缩粉,然后用瓶装备用。
对比实验:本公司选用甲组:颈椎病患者10例、腰椎病患者10例,乙型肝炎患者10例、高血压患者10例、高血脂患者10例、咳嗽患者10例;乙组:颈椎病患者10例、腰椎病患者10例,乙型肝炎患者10例、高血压患者10例、高血脂患者10例、咳嗽患者10例:甲组使用平卧菊三七低热恒温制剂法制得制剂(制备方法一、制得的制剂);乙组使用制备方法二制得的制剂,用法与用量等同,每天二次,每次3克,每天进行疗效对比评价,通过一个月的对比试用、发现甲组无论是从疗效、速度、还是从康复率,都明显优于乙组;这种对比实验,在近三年内做过很多次,所得的结果、都是采用平卧菊三七低热恒温制剂法<即制备方法一>制得的制剂的疗效、远超制备方法二制剂的疗效,本公司采用制备方法一制得的堂专家平卧菊三七制剂,治疗风湿骨痛、颈椎病、腰椎病、心脑血管病、中风后遗症、脑萎缩、头痛、头昏、抽筋、乙肝、血吸虫病、高血压、高血脂、高血糖、补钙、感冒、咳嗽、哮喘的病患有数千余例,疗效显著、未出现任何毒副作用。
实施例:一、刘xx,男,40岁,2010年2月8日查出乙肝大三阳、肝功能时好时坏、乙肝病毒阳性,免疫力差、经常感冒咳嗽,有高血压、高血脂、高血糖,几年来为了这些毛病到各地求医用药,病情无明显好转,于2015年8月来此就诊,本人因无工作、身体又差、资金确有困难,在我的建议下、使用按制备方法一(平卧菊三七低热恒温制剂法)制得的(堂专家平卧菊三七)制剂,每日二次、每次3克,连续使用1个月后明显好转,继续使用了8个月、停药2个月后复查肝功能正常、大三阳转小三阳、乙肝病毒转阴,血压、血脂、血糖正常,免疫力明显增强,平日再未出现头痛、头昏及感冒咳嗽症状,随访至今一切正常。
二、张××,女,50岁,于2012年5月8日发现类风湿、颈椎病、腰椎病、到处求医无明显好转,痛疼无比、几年来生活在痛苦之中,2016年8月8日、由亲友介绍前来就诊,本人给她开了十五天、按制备方法一(平卧菊三七低热恒温制剂法)制备的(堂专家平卧菊三七)制剂,每日二次、每次3g,十天明显好转,日后继续使用此制剂、共计用了十个月,停药半年后复查、类风湿因子为阴性、颈椎、腰椎再无痛疼感觉,回仿直今、一切正常。
三、吴xx,男,67岁,52岁时患上哮喘(现有十五年),随着年临的增大、心功能出现异常、腿经常抽筋,近几年来到处求医无好转、因平日活动少、2015年12月引发高血压轻度中风和脑萎缩,病情越来越重,已不能正常步行,2016年1月8日使用按制备方法一(平卧菊三七低热恒温制剂法)制取的(堂专家平卧菊三七)制剂,每日二次、每次3g,第五天病情得到控制,用药6个月后、咳嗽、哮喘基本治愈,能正常行走、生活上能自理,至今身体键康、未复化。
Claims (1)
1.平卧菊三七制剂、其特征是制剂的制备方法分以下流程:1、取少量的平卧菊三七鲜品经凉干、消毒、制成精细粉,然后贮藏备用;2、将大量的平卧菊三七鲜品、用大型榨汁机进行榨汁碎取;3、将榨汁后的平卧三七进行液、渣过滤,让液渣分离(为提高利用率、滤渣可加入适量食用酒精泡上2天左右进行重复过滤);4、将滤液加入第1步所制备的平卧菊三七粉适量(加入的制备粉的多少来确定产品浓缩比的比例)、制成(液、粉)混合物,然后将混合物、平布于不锈钢平板上或盆中、在50度温度的恒温烤房中进行干燥;5、将干燥品进行粉碎精细、用红外线进行杀菌后,进行包装、贮存备用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910921005.0A CN110585256A (zh) | 2019-09-19 | 2019-09-19 | 平卧菊三七制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910921005.0A CN110585256A (zh) | 2019-09-19 | 2019-09-19 | 平卧菊三七制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110585256A true CN110585256A (zh) | 2019-12-20 |
Family
ID=68864099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910921005.0A Pending CN110585256A (zh) | 2019-09-19 | 2019-09-19 | 平卧菊三七制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110585256A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111081325A (zh) * | 2019-12-27 | 2020-04-28 | 医渡云(北京)技术有限公司 | 医疗数据处理方法与装置 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106922894A (zh) * | 2015-12-30 | 2017-07-07 | 北京万源普达医疗科技有限公司 | 一种平卧菊三七茶及其制备方法 |
CN108029820A (zh) * | 2017-12-08 | 2018-05-15 | 浙江省农业科学院 | 一种明日叶混合青汁粉及其制备方法和应用 |
-
2019
- 2019-09-19 CN CN201910921005.0A patent/CN110585256A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106922894A (zh) * | 2015-12-30 | 2017-07-07 | 北京万源普达医疗科技有限公司 | 一种平卧菊三七茶及其制备方法 |
CN108029820A (zh) * | 2017-12-08 | 2018-05-15 | 浙江省农业科学院 | 一种明日叶混合青汁粉及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
何顺志等: "《贵州中草药资源研究》", 30 September 2007, 贵州科技出版社 * |
倪凯: "《傣医外治法常用药与经验方》", 30 April 2015, 上海科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111081325A (zh) * | 2019-12-27 | 2020-04-28 | 医渡云(北京)技术有限公司 | 医疗数据处理方法与装置 |
CN111081325B (zh) * | 2019-12-27 | 2023-12-12 | 医渡云(北京)技术有限公司 | 医疗数据处理方法与装置 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101880894B1 (ko) | 혼합 생약제 추출물을 유효성분으로 포함하는 숙취해소, 피로회복 및 면역력 증강용 식품 조성물 | |
CN104982599A (zh) | 一种植物凉茶浓缩液及低糖植物凉茶饮料 | |
CN103602551B (zh) | 一种有助于消食健胃复方中草药发酵保健酒及其生产方法 | |
KR101539864B1 (ko) | 숙취해소 음료 | |
CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN105213256A (zh) | 一种舒敏祛红柔肤水及其制备方法 | |
CN104083438A (zh) | 一种缓解高血压的苦瓜中药制剂及制备方法 | |
CN110585256A (zh) | 平卧菊三七制剂 | |
KR102659842B1 (ko) | 차전자피 및 복합추출물을 포함하는 장 기능 개선 및 배변 촉진용 건강기능식품 조성물 및 이의 제조방법 | |
CN105767402A (zh) | 一种甘草甜素生姜茶及其制备方法和应用 | |
CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
CN104814221B (zh) | 一种罗汉果和金银花的茶饮料 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
JPH0773478B2 (ja) | 保健食品組成物の製造方法 | |
CN105194443A (zh) | 一种用于治疗小儿湿疹的中药组合物及其制备方法 | |
CN104606571A (zh) | 一种生津止渴鲜菠菜根代茶饮及制备方法 | |
CN104673572A (zh) | 具有美容养颜功效的抗衰老葡萄酒及制备方法 | |
KR101723962B1 (ko) | 친환경 천연성분을 이용한 아토피 피부염 완화용 기능성 조성물 | |
CN104069399A (zh) | 消除消化不良型口臭的中药汤剂及制备方法 | |
CN106924578A (zh) | 一种治疗痈疖肿毒的中药 | |
CN103599271B (zh) | 一种治疗子宫肌瘤的中药 | |
CN116459314B (zh) | 一种延缓衰老喷剂 | |
CN105455004A (zh) | 一种胃下垂患者食用的面条 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191220 |